Impact of decreased insulin resistance by ezetimibe on postprandial lipid profiles and endothelial functions in obese, non-diabetic-metabolic syndrome patients with coronary artery disease-Reference-Cited by-同舟云学术

Impact of decreased insulin resistance by ezetimibe on postprandial lipid profiles and endothelial functions in obese, non-diabetic-metabolic syndrome patients with coronary artery disease

Published:2018-12-05 Issue:6 Volume:34 Page:916-925
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Nakamura Akihiro,Sato Kenjiro,Kanazawa Masanori,Kondo Masateru,Endo Hideaki,Takahashi Tohru,Nozaki Eiji

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-018-1319-x.pdf

Reference38 articles.

1. Tanaka A (2004) Postprandial hyperlipidemia and atherosclerosis. J Atheroscler Thromb 11:322–329

2. Søndergaard E, Johansen RF, Jensen MD, Nielsen S (2017) Postprandial VLDL-TG metabolism in type 2 diabetes. Metabolism 75:25–35

3. Masuda D, Yamashita S (2017) Postprandial hyperlipidemia and remnant lipoproteins. J Atheroscler Thromb 24:95–109

4. Kim IY, Park S, Chou TH, Trombold JR, Coyle EF (2016) Prolonged sitting negatively affects the postprandial plasma triglyceride-lowering effect of acute exercise. Am J Physiol Endocrinol Metab 311:E891–E898

5. Roche HM, Gibney MJ (2000) The impact of postprandial lipemia in accelerating atherothrombosis. J Cardiovasc Risk 7:317–324

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies;Metabolites;2024-07-17

2. Combining Ezetimibe and Rosuvastatin: Impacts on Insulin Sensitivity and Vascular Inflammation in Patients with Type 2 Diabetes Mellitus;Diabetes & Metabolism Journal;2024-01-31

3. Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments;International Journal of Molecular Sciences;2023-09-11

4. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022;Journal of Atherosclerosis and Thrombosis;2023

5. Insulin resistance and cardiovascular diseases: focus on common in pathogenesis and treatment.;Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini;2023